BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30793953)

  • 1. Progress of Exosomes in the Diagnosis and Treatment of Pancreatic Cancer.
    Wu H; Chen X; Ji J; Zhou R; Liu J; Ni W; Qu L; Ni H; Ni R; Bao B; Xiao M
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):215-222. PubMed ID: 30793953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.
    Jin H; Wu Y; Tan X
    Clin Transl Oncol; 2017 Aug; 19(8):921-930. PubMed ID: 28168600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?
    Moutinho-Ribeiro P; Macedo G; Melo SA
    Front Endocrinol (Lausanne); 2018; 9():779. PubMed ID: 30671023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes in Pancreatic Cancer: from Early Detection to Treatment.
    Armstrong EA; Beal EW; Chakedis J; Paredes AZ; Moris D; Pawlik TM; Schmidt CR; Dillhoff ME
    J Gastrointest Surg; 2018 Apr; 22(4):737-750. PubMed ID: 29423813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression.
    Nuzhat Z; Kinhal V; Sharma S; Rice GE; Joshi V; Salomon C
    Oncotarget; 2017 Mar; 8(10):17279-17291. PubMed ID: 27999198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer and associated exosomes.
    Zhao C; Gao F; Weng S; Liu Q
    Cancer Biomark; 2017 Dec; 20(4):357-367. PubMed ID: 29036786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exosomes as drug carriers in chemotherapy of pancreatic cancer.
    Xu B; Zuo C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 48(2):268-274. PubMed ID: 36999474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions and clinical applications of exosomes in pancreatic cancer.
    Jiang Z; Wang H; Mou Y; Li L; Jin W
    Mol Biol Rep; 2022 Nov; 49(11):11037-11048. PubMed ID: 36097109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
    Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
    Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes as therapeutic solutions for pancreatic cancer.
    Farran B; Nagaraju GP
    Drug Discov Today; 2020 Dec; 25(12):2245-2256. PubMed ID: 33127355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Exosomes in Pancreatic Cancer.
    Lan B; Zeng S; Grützmann R; Pilarsky C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
    Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
    Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current research status and progress in comprehensive diagnosis and treatment of pancreatic cancer in the era of targeted therapy].
    Zhang ZK; Yang YM
    Zhonghua Wai Ke Za Zhi; 2020 Jan; 58(1):22-26. PubMed ID: 31902165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in the early diagnosis of pancreatic cancer.
    Zhang Q; Chen S; Zeng L; Chen Y; Lian G; Qian C; Li J; Xie R; Huang KH
    Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):149-156. PubMed ID: 27937041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive survey into the role of exosomes in pancreatic cancer; from the origin of cancer to the progress and possibility of diagnosis and treatment.
    Farahmand Y; Tehrany PM; Nazari A; Nava ZH; Alsaffar MF; Yazdani O; Adili A; Esbati R; Ghafouri K
    Pathol Res Pract; 2023 May; 245():154465. PubMed ID: 37119731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
    Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
    Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential roles of exosomes in pancreatic cancer initiation and metastasis.
    Sun W; Ren Y; Lu Z; Zhao X
    Mol Cancer; 2020 Sep; 19(1):135. PubMed ID: 32878635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: Key roles in the hallmarks of cancer.
    Channon LM; Tyma VM; Xu Z; Greening DW; Wilson JS; Perera CJ; Apte MV
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188728. PubMed ID: 35385773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insight into the Role of Exosomes in Pancreatic Cancer.
    Wang CC; Zhao YM; Wang HY; Zhao YP
    Ann Clin Lab Sci; 2019 May; 49(3):385-392. PubMed ID: 31308040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.